Data indicate that vaspin may be a new drug designed to treat diabetes due to its insulin-sensitizing effect in WAT and inhibitory properties on gene expression associated with insulin resistance [11], as well as its stimulatory effect on insulin secretion [55]. The gene discussed is INS; the disease is Insulin resistance.